24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Entera Bio
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:28
Full list of Israeli high-tech layoffs in 2024
16:26
Bluevine cuts 100 jobs in second round of layoffs in six months
15:20
What’s behind China’s late investigation into Nvidia’s acquisition of Mellanox?
15:00
Astrix Security nets $45M Series B led by Menlo and Anthropic to enhance AI era identity protection
More stories
Buzz
Most popular
Daily
Weekly
1
Thoma Bravo cashes in with $372M sale of CyberArk shares after stock surge
2
AI startup Aporia in talks to be acquired for tens of millions of dollars
3
Ibex Investors rocked by departure of key Israeli partners
4
Riverside nets $30M Series C as Oren Zeev and Alexis Ohanian double down on content creation platform
5
Hello, Neumann: Aussie serial investor takes Israel by storm
More news
Entera Bio
3 stories about Entera Bio
Fourth Time’s the Charm for Entera Bio IPO
01.07.18
|
Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Entera Bio Files for Nasdaq IPO
12.11.17
|
Lilach Baumer
The clinical stage company develops treatments mostly for osteoporosis and bone disorders
IPO Hopeful Entera Bio Moves to Better Position
13.09.17
|
Dror Reich
Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism
Please ensure Javascript is enabled for purposes of
website accessibility